Medical Research
(H20Z)
IRS Verified
DX Registered
990 on File
FSHD SOCIETY
Financial strength (30%)
79/100
Reliability (20%)
55/100
Effectiveness (25%)
81/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Our Promise As long as we are here, no patient need ever face this disease alone. The FSHD Society is deeply committed to working with ingenuity and integrity to accelerate research leading to treatments and a cure. It is the generous support - gifts of time, talent, and treasure - from patients, families, friends, major donors, and sponsors, that make this imperative work possible. Our Mission Find treatments and a cure for FSHD while empowering our families.
Financial Overview — FY 2023
$4.5M
Total Revenue
$4.3M
Total Expenses
$5.0M
Net Assets
18
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
77.7%
Fundraising Efficiency
392.9%
Operating Reserve
13.96x
Liability-to-Asset
21.9%
Revenue Diversification
92.2%
Executive Compensation
$660K
Compared with Peers
FY 2023
Compared with 479 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
77.7% | 82.4% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
10.1% | 11.9% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
12.3% | 1.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
392.9% | 134.1% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
14.0 mo | 14.9 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
21.9% | 11.5% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
92.2% | 93.1% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
27.0% | 7.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-8.5% | 12.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
3.2% | 0.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $4.5M | $4.3M | $5.0M | 77.7% | 18 |
| 2022 | $3.5M | $4.7M | $4.7M | 83.4% | 17 |
| 2021 | $5.5M | $4.6M | N/A | — | 15 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.